INTERNATIONAL PATENT: INNOLAKE BIOPHARMA (HANGZHOU) CO., LTD., 英诺湖医药（杭州）有限公司 FILES APPLICATION FOR "ANTI-B7H3 ANTIBODY-ERIBULIN CONJUGATE FORMULATION, PREPARATION METHOD THEREFOR AND USE THEREOF"

GENEVA, Feb. 2 -- INNOLAKE BIOPHARMA (HANGZHOU) CO., LTD. (Room 301, Building 24, Yinhai Science Invention Center, Xiasha SubdistrictHangzhou, Zhejiang 310018), 英诺湖医药（杭州）有限公司 (中国浙江省杭州市下沙街道银海科创中心24幢301室) filed a patent application (PCT/CN2025/109071) for "ANTI-B7H3 ANTIBODY-ERIBULIN CONJUGATE FORMULATION, PREPARATION METHOD THEREFOR, AND USE THEREOF" on Jul 17, 2025. With publication no. WO/2026/021323, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was...